相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Suppression of local type I interferon by gut microbiota-derived butyrate impairs antitumor effects of ionizing radiation
Kaiting Yang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Radiotherapy and the gut microbiome: facts and fiction
Jing Liu et al.
RADIATION ONCOLOGY (2021)
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Erez N. Baruch et al.
SCIENCE (2021)
CAR T cells in solid tumors: challenges and opportunities
Faroogh Marofi et al.
STEM CELL RESEARCH & THERAPY (2021)
Five-Year Outcomes for Refractory B-Cell Lymphomas with CAR T-Cell Therapy
Elise A. Chong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients
Diwakar Davar et al.
SCIENCE (2021)
Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progression
Stefano Pierini et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids
Chang H. Kim
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
The Functional and Mechanistic Roles of Immunoproteasome Subunits in Cancer
Satyendra Chandra Tripathi et al.
CELLS (2021)
CAR-T cell therapy: current limitations and potential strategies
Robert C. Sterner et al.
BLOOD CANCER JOURNAL (2021)
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade
Miles C. Andrews et al.
NATURE MEDICINE (2021)
Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer
Maik Luu et al.
NATURE COMMUNICATIONS (2021)
Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response
Mireia Uribe-Herranz et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic Leukemia
Noelle Frey et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
Michael Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Intestinal microbiota: a new force in cancer immunotherapy
Zhujiang Dai et al.
CELL COMMUNICATION AND SIGNALING (2020)
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
Jeremy S. Abramson et al.
LANCET (2020)
Health and disease markers correlate with gut microbiome composition across thousands of people
Ohad Manor et al.
NATURE COMMUNICATIONS (2020)
Deciphering functional redundancy in the human microbiome
Liang Tian et al.
NATURE COMMUNICATIONS (2020)
CD103+ cDC1 and endogenous CD8+ T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function
Nicholas F. Kuhn et al.
NATURE COMMUNICATIONS (2020)
A guide to cancer immunotherapy: from T cell basic science to clinical practice
Alex D. Waldman et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Host-microbiota interactions in inflammatory bowel disease
Roberta Caruso et al.
NATURE REVIEWS IMMUNOLOGY (2020)
The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolic-epigenetic crosstalk in lymphocytes
Maik Luu et al.
NATURE COMMUNICATIONS (2019)
Dendritic Cells and Cancer: From Biology to Therapeutic Intervention
Ben Wylie et al.
CANCERS (2019)
pathfindR: An R Package for Comprehensive Identification of Enriched Pathways in Omics Data Through Active Subnetworks
Ege Ulgen et al.
FRONTIERS IN GENETICS (2019)
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Stephen J. Schuster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The Intriguing History of Cancer Immunotherapy
Paula Dobosz et al.
FRONTIERS IN IMMUNOLOGY (2019)
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
V. Gopalakrishnan et al.
SCIENCE (2018)
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Bertrand Routy et al.
SCIENCE (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Current Concepts of Antigen Cross-Presentation
Maria Embgenbroich et al.
FRONTIERS IN IMMUNOLOGY (2018)
Radiation Therapy As a Bridging Strategy for Refractory Diffuse Large B Cell Lymphoma Patients Awaiting CAR T Manufacturing of Axicabtagene Ciloleucel
Michael D. Jain et al.
BLOOD (2018)
Gut microbiota modulates adoptive cell therapy via CD8α dendritic cells and IL-12
Mireia Uribe-Herranz et al.
JCI INSIGHT (2018)
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
S. S. Neelapu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Butyrate and propionate inhibit antigen-specific CD8+ T cell activation by suppressing IL-12 production by antigen-presenting cells
Claudia Nastasi et al.
SCIENTIFIC REPORTS (2017)
Augmentation of Antitumor Immunity by Human and Mouse CAR T Cells Secreting IL-18
Biliang Hu et al.
CELL REPORTS (2017)
A simple, clinically relevant therapeutic vaccine shows long-term protection in an aggressive, delayed-treatment B lymphoma model
Pallab Pradhan et al.
JCI INSIGHT (2017)
Dysbiosis and the immune system
Maayan Levy et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Transcriptional Control of Dendritic Cell Development
Theresa L. Murphy et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 34 (2016)
How Do Cytotoxic Lymphocytes Kill Cancer Cells?
Luis Martinez-Lostao et al.
CLINICAL CANCER RESEARCH (2015)
Batf3 maintains autoactivation of Irf8 for commitment of a CD8α+ conventional DC clonogenic progenitor
Gary E. Grajales-Reyes et al.
NATURE IMMUNOLOGY (2015)
Selective and efficient generation of functional Batf3-dependent CD103+ dendritic cells from mouse bone marrow
Christian Thomas Mayer et al.
BLOOD (2014)
Antigen-specific T-cell activation independently of the MHC: chimeric antigen receptor-redirected T cells
Markus Chmielewski et al.
FRONTIERS IN IMMUNOLOGY (2013)
Systemic absorption of oral vancomycin in patients with Clostridium difficile infection
Sriharsha Rao et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2011)
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
Michael Kalos et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
MHC class I antigen presentation: learning from viral evasion strategies
Ted H. Hansen et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Biochemical differentiation and comparison of Desulfovibrio species and other phenotypically similar genera
YA Warren et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Role of TAP-1 and/or TAP-2 antigen presentation defects in tumorigenicity of mouse melanoma
S Agrawal et al.
CELLULAR IMMUNOLOGY (2004)
Critical components of a DNA fusion vaccine able to induce protective cytotoxic T cells against a single epitope of a tumor antigen
J Rice et al.
JOURNAL OF IMMUNOLOGY (2002)